Samara plans to use 70% of the proposed fund for buyout or control transactions while the remaining will be used for acquiring significant ...

"Samara Capital is bullish on this segment and 7-8 brands which are part of the anti-infective portfolio will be acquired as part of the de...

As part of the deal, Samara Capital's managing director Gautam Gode and vice president Abhishek Kabra will come on SMT's board.